Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Cox

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
Optometry and Vision Science : Official Publication of the American Academy of Optometry|May 7, 2015
Does correcting astigmatism with toric lenses improve driving performance?Daniel J Cox, Thomas Banton, Steven Record, et al.
Diabetes Technology & Therapeutics|November 18, 2006
A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitusAnthony L McCall, Daniel J Cox, John Crean, et al.
Diabetes Care|March 17, 2007
Prediction of severe hypoglycemiaDaniel J Cox, Linda Gonder-Frederick, Lee Ritterband, et al.
Diabetes/Metabolism Research and Reviews|October 25, 2002
The metabolic demands of driving for drivers with type 1 diabetes mellitusDaniel J Cox, Linda A Gonder-Frederick, Boris P Kovatchev, et al.
Diabetes Care|July 28, 2004
Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator dataBoris P Kovatchev, Linda A Gonder-Frederick, Daniel J Cox, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|October 20, 2006
Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with Attention-Deficit/Hyperactivity DisorderH Kent Wilson, Daniel J Cox, R Lawrence Merkel, et al.
JMIR Diabetes|January 20, 2022
An Innovative, Paradigm-Shifting Lifestyle Intervention to Reduce Glucose Excursions With the Use of Continuous Glucose Monitoring to Educate, Motivate, and Activate Adults With Newly Diagnosed Type 2 Diabetes: Pilot Feasibility StudyTamara K Oser, Mark Cucuzzella, Marilyn Stasinopoulos, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|April 13, 2004
Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: a pilot studyDaniel J Cox, R Lawrence Merkel, Jennifer Kim Penberthy, et al.
Journal of the Endocrine Society|October 23, 2020
Minimizing Glucose Excursions (GEM) With Continuous Glucose Monitoring in Type 2 Diabetes: A Randomized Clinical TrialDaniel J Cox, Tom Banton, Matthew Moncrief, et al.
Pediatrics|September 5, 2006
Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorderDaniel J Cox, R Lawrence Merkel, Melissa Moore, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
Optometry and Vision Science : Official Publication of the American Academy of Optometry|May 7, 2015
Does correcting astigmatism with toric lenses improve driving performance?Daniel J Cox, Thomas Banton, Steven Record, et al.
Diabetes Technology & Therapeutics|November 18, 2006
A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitusAnthony L McCall, Daniel J Cox, John Crean, et al.
Diabetes Care|March 17, 2007
Prediction of severe hypoglycemiaDaniel J Cox, Linda Gonder-Frederick, Lee Ritterband, et al.
Diabetes/Metabolism Research and Reviews|October 25, 2002
The metabolic demands of driving for drivers with type 1 diabetes mellitusDaniel J Cox, Linda A Gonder-Frederick, Boris P Kovatchev, et al.
Diabetes Care|July 28, 2004
Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator dataBoris P Kovatchev, Linda A Gonder-Frederick, Daniel J Cox, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|October 20, 2006
Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with Attention-Deficit/Hyperactivity DisorderH Kent Wilson, Daniel J Cox, R Lawrence Merkel, et al.
JMIR Diabetes|January 20, 2022
An Innovative, Paradigm-Shifting Lifestyle Intervention to Reduce Glucose Excursions With the Use of Continuous Glucose Monitoring to Educate, Motivate, and Activate Adults With Newly Diagnosed Type 2 Diabetes: Pilot Feasibility StudyTamara K Oser, Mark Cucuzzella, Marilyn Stasinopoulos, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|April 13, 2004
Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: a pilot studyDaniel J Cox, R Lawrence Merkel, Jennifer Kim Penberthy, et al.
Journal of the Endocrine Society|October 23, 2020
Minimizing Glucose Excursions (GEM) With Continuous Glucose Monitoring in Type 2 Diabetes: A Randomized Clinical TrialDaniel J Cox, Tom Banton, Matthew Moncrief, et al.
Pediatrics|September 5, 2006
Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorderDaniel J Cox, R Lawrence Merkel, Melissa Moore, et al.
Pageof 10